ArticleVaccine2022
COVID-19 vaccine express strategy in Malawi: An effort to reach the un-reach.
Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 11 citations in OpenAlex.
- Characterising protective immune responses to SARS-CoV-2 in urban and rural Malawi between February 2021 and April 2022.Scientific reports · 2025Article
- The cost of delivering COVID-19 vaccines in four districts in Malawi.Cost effectiveness and resource allocation : C/E · 2025Article
- Evaluating self-reported vaccination hesitancy in mobile phone surveys in low- and middle-income countries: learned lessons from Ethiopia, Indonesia, Kenya, and Malawi.Journal of global health · 2025Article
- COVID-19 severity and vaccine effectiveness in Malawi: A test-negative case-control study.Journal of public health in Africa · 2025Article
- COVID-19 vaccine uptake, barriers and associated factors among healthcare workers in Malawi.Journal of public health in Africa · 2025Article
- Mortality risk information and health-seeking behavior during an epidemic.Proceedings of the National Academy of Sciences of the United States of America · 2024Article
- Knowledge, attitudes and demographic drivers for COVID-19 vaccine hesitancy in Malawi.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo establish the impact of "Covid-19 Vaccination express" (CVE) on vaccine uptake in Malawi.
designRetrospective cross-sectional study to compare the daily vaccine administration rate in CVE and routine covid vaccination (RCV). RCV data was collected from March 2021 to October 2021. The data regarding CVE was collected from 5 November 2021 to 31 December 2021. Data was collected regarding (1) the total number and type of vaccine doses administered and (2) Demographic details like age, gender, occupation, presence of comorbidities, the first dose, or the second dose of the people who received a vaccine.
resultsFrom March-December 2021, a total of 1,866,623 COVID-19 vaccine doses were administered, out of which 1,290,145 doses were administered at a mean daily vaccination rate of 1854 (95 % CI: 1292-2415) doses as a part of RCV, and 576,478 doses were administered at a mean daily vaccination rate of 3312 (95 % CI: 2377-4248) doses as a part of CVE. Comparing the mean daily doses (Astra Zeneca, AZ doses 1 & 2) administered in the CVE and RCV showed that the mean daily doses of AZ vaccine administered were significantly higher in the CVE (p < 0.05).
conclusionCVE successfully increased the uptake of the Covid-19 vaccine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.